Innovative diagnosticsand therapeuticsfor metabolic disease
Back to News list
- NUTRINOSTICS FOR THE EARLY DIAGNOSIS AND PREVENTION OF NASH
NUTRINOSTICS FOR THE EARLY DIAGNOSIS AND PREVENTION OF NASH
18 02 2020
CellMade, a biopharmaceutical company actively engaged in the discovery of biomarkers and the development of medical nutrition products for the early diagnosis and preventive treatment of metabolic and inflammatory disease, discloses its combined systems biology and translational research strategy.